Use of the six-minute walk test to characterize golden retriever muscular dystrophy

Mendell, 2012, Evidence-based path to newborn screening for Duchenne muscular dystrophy, Ann Neurol, 71, 304, 10.1002/ana.23528 Bushby, 2010, Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management, Lancet Neurol, 9, 77, 10.1016/S1474-4422(09)70271-6 Bushby, 2010, Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care, Lancet Neurol, 9, 177, 10.1016/S1474-4422(09)70272-8 Caskey, 1980, Sporadic occurrence of Duchenne muscular dystrophy: evidence for new mutation, Clin Genet, 18, 329, 10.1111/j.1399-0004.1980.tb02293.x Flanigan, 2009, Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort, Hum Mutat, 30, 1657, 10.1002/humu.21114 Flanigan, 2014, Duchenne and Becker muscular dystrophies, Neurol Clin, 32, 671, 10.1016/j.ncl.2014.05.002 Desguerre, 2009, Clinical heterogeneity of Duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up, PLoS ONE, 4, 10.1371/journal.pone.0004347 Humbertclaude, 2012, Motor and respiratory heterogeneity in Duchenne patients: implication for clinical trials, Eur J Paediatr Neurol, 16, 149, 10.1016/j.ejpn.2011.07.001 Bulfield, 1984, X chromosome-linked muscular dystrophy (mdx) in the mouse, Proc Natl Acad Sci USA, 81, 1189, 10.1073/pnas.81.4.1189 Gillis, 1999, Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse, J Muscle Res Cell Motil, 20, 605, 10.1023/A:1005545325254 Cooper, 1988, The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs, Nature, 334, 154, 10.1038/334154a0 Kornegay, 1988, Muscular dystrophy in a litter of golden retriever dogs, Muscle Nerve, 11, 1056, 10.1002/mus.880111008 Kornegay, 2011, Golden retriever muscular dystrophy (GRMD): developing and maintaining a colony and physiological functional measurements, Methods Mol Biol, 709, 105, 10.1007/978-1-61737-982-6_7 Barthelemy, 2014, Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy, Dis Model Mech, 7, 1253, 10.1242/dmm.016014 Kornegay, 2012, Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies, Mamm Genome, 23, 85, 10.1007/s00335-011-9382-y Gaiad, 2011, Physical therapy assessment tools to evaluate disease progression and phenotype variability in Golden Retriever muscular dystrophy, Res Vet Sci, 91, 188, 10.1016/j.rvsc.2011.01.007 Lynn, 2015, Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy, Neuromuscul Disord, 25, 96, 10.1016/j.nmd.2014.09.003 Scott, 2012, Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy, Physiother Res Int, 17, 101, 10.1002/pri.520 McDonald, 2010, The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy, Muscle Nerve, 41, 500, 10.1002/mus.21544 Boddy, 2004, Evaluation of the six-minute walk test in dogs, Am J Vet Res, 65, 311, 10.2460/ajvr.2004.65.311 Swimmer, 2011, Evaluation of the 6-minute walk test in pet dogs, J Vet Intern Med, 25, 405, 10.1111/j.1939-1676.2011.0689.x Lilja-Maula, 2014, Long-term outcome and use of 6-minute walk test in West Highland White Terriers with idiopathic pulmonary fibrosis, J Vet Intern Med, 28, 379, 10.1111/jvim.12281 McDonald, 2013, The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study, Muscle Nerve, 48, 343, 10.1002/mus.23902 Mazzone, 2013, 24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy, PLoS ONE, 8, 10.1371/annotation/cbe611fe-cda9-4d98-9574-0ac18e109daa Bartlett, 1996, Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs, Am J Vet Res, 57, 650 Kornegay, 1999, Contraction force generated by tarsal joint flexion and extension in dogs with golden retriever muscular dystrophy, J Neurol Sci, 166, 115, 10.1016/S0022-510X(99)00118-5 Kornegay, 2014, NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy, Skelet Muscle, 4, 18, 10.1186/2044-5040-4-18 Hudgson, 1967, Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity, J Neurol Neurosurg Psychiatry, 30, 416, 10.1136/jnnp.30.5.416 Kornegay, 1994, Tarsal joint contracture in dogs with golden retriever muscular dystrophy, Lab Anim Sci, 44, 331 Kornegay, 2016, Regenerative medicine for degenerative muscle diseases Patronek, 1997, Comparative longevity of pet dogs and humans: implications for gerontology research, J Gerontol A Biol Sci Med Sci, 52 Vignos, 1963, Management of progressive muscular dystrophy in childhood, JAMA, 184, 89, 10.1001/jama.1963.03700150043007 McDonald, 1995, Profiles of neuromuscular diseases. Duchenne muscular dystrophy, Am J Phys Med Rehabil, 74, S70, 10.1097/00002060-199509001-00003 Nicholson, 1993, Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups, J Med Genet, 30, 728, 10.1136/jmg.30.9.728 Florence, 1985, Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology?, Neurology, 35, 758, 10.1212/WNL.35.5.758 Dahlqvist, 2014, A pilot study of muscle plasma protein changes after exercise, Muscle Nerve, 49, 261, 10.1002/mus.23909 Griffiths, 1966, Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity, Clin Chim Acta, 13, 413, 10.1016/0009-8981(66)90230-0 Nicholson, 1986, The effect of aerobic exercise on serum creatine kinase activities, Muscle Nerve, 9, 820, 10.1002/mus.880090905 Kobayashi, 2012, Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies, Neuromuscul Disord, 22, 34, 10.1016/j.nmd.2011.08.001 Valentine, 1988, Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies, J Neurol Sci, 88, 69, 10.1016/0022-510X(88)90206-7 Valentine, 1989, The effect of exercise on canine dystrophic muscle, Ann Neurol, 26, 588, 10.1002/ana.410260416 Chanoit, 2001, Use of plasma creatine kinase pharmacokinetics to estimate the amount of exercise-induced muscle damage in Beagles, Am J Vet Res, 62, 1375, 10.2460/ajvr.2001.62.1375 Kornegay, 2014, Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials, ILAR J, 55, 119, 10.1093/ilar/ilu011 Vieira, 2015, Jagged 1 rescues the Duchenne muscular dystrophy phenotype, Cell, 163, 1204, 10.1016/j.cell.2015.10.049 Guerra-Balic, 2015, Reliability and validity of the 6-min walk test in adults and seniors with intellectual disabilities, Res Dev Disabil, 47, 144, 10.1016/j.ridd.2015.09.011